Protein Crystallization and Crystallography Market Growing at a CAGR of 8.9% – Increasing Focus on Miniaturization

protein crystallization and crystallography market

PUNE, India, 2021-May-07 — /EPR Network/ —

The Protein Crystallization and Crystallography Market is attributed to the increasing adoption of protein therapeutics, technological advancements in protein crystallization instruments and consumables, and the increasing focus on miniaturization. However, the high cost of instruments is expected to restrain the growth of this market during the forecast period.

The report “Protein Crystallization and Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region – Global Forecast to 2025“, the Protein Crystallization Market is projected to reach USD 1.7 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 8.9% during the forecast period.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=147057058

Protein Crystallization Market Segmentation in Detailed:

On the basis of product and service, the consumables segment accounted for the largest share of the Protein Crystallization and Crystallography Market in 2019. This can be attributed to a large number of reagent kits and microplates used in proteomics research and the increasing demand for miniature screening plates in automated liquid handlers.

The pharmaceutical companies segment accounted for the largest share of the protein crystallography market in 2019. This can be attributed to the increasing demand for protein-based drugs and the increasing demand for biologics in various application areas.

Geographical View in-detailed:

The protein crystallization and crystallography market is divided into five major regions, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the global market, followed by Europe. The growth in this market can be attributed to the increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, and the rising demand for high-quality research tools.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=147057058

Recent Developments in Depth:

• In 2020, Calibre Scientific (US) acquired NeXtal Biotechnologies (Product Line of QIAGEN) (Netherlands) to strengthen its portfolio of structural biology solutions.
• In 2019, Charles River Laboratories (US) collaborated with CHDI Foundation (US) for the drug discovery and development of therapies for Huntington’s disease.
• In 2018, Bruker Corporation launched a new product, D8 DISCOVER Plus X-ray Diffraction (XRD).

Global Key Leaders:

The major companies in the protein crystallization and crystallography market are Rigaku Corporation (Japan), Hampton Research (US), Jena Bioscience GmbH (Germany), and Bruker Corporation (US).

Rigaku Corporation (Japan) – The company is a leading manufacturer and supplier of scientific instruments. The company offers advanced analytical and industrial instruments based on X-ray fluorescence spectrometry, small-molecule X-ray crystallography, small-angle X-ray scattering, X-ray diffraction, Raman spectroscopy, X-ray optics, X-ray sources, semiconductor metrology, computed tomography, nondestructive testing, and thermal analysis. The company’s business units include Life Science; Environment, Resources, and Energy; Nanotechnology and Materials; Semiconductor and Electronics; and Safety and Security.